๐ฐ Preliminary Phase News
Preliminary Phase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Preliminary Phase. Real-time updates on events, politics, business and more.
May 1, 2024
โ Dordaviprone (ONC201) ACTION Study Progressing; Reiterates Expectations for Interim Overall Survival (OS) Data in 2025 and Final OS Data in 2026...
November 29, 2023
EconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical insights for market professionals and those who want to make informed investment decisions.
November 2, 2023
First presentation of clinical data from ongoing COVALENT-101 trial of covalent menin inhibitor BMF-219 as a treatment for patients with liquid tumorsTrial in progress presentation featuring study...
July 22, 2023
[WATCHLIVE]UPDATES]*Italy v USA Volleyball LIVE Broadcast Free ON Tv Channel 22. 7. 2023
July 22, 2023
Italy vs United States: Date, time and TV Channel to watch or live stream in the US 2023 FIVB Volleyball Men's Nations League today
June 3, 2023
TEHRAN (Tasnim) โ Iranโs volleyball team will play France in a warm-up match on Sunday.
May 11, 2023
EQS-News: MorphoSys AG / Key word: Miscellaneous MorphoSys Highlights Potential of Its Mid- to Late-Stage Oncology Pipeline at 2023 ASCO and EHA Annual Meetings 11.05.2023 / 18:39... | May 11, 2023
May 11, 2023
EQS-News: MorphoSys AG / Key word(s): MiscellaneousMorphoSys Highlights Potential of Its Mid- to Late-Stage Oncology Pipeline at 2023 ASCO and EHA Annual Meetings 11.05.2023 / 18:39 CET/CESTThe issuer is solely responsible for the content of this announcement.Media ReleasePlanegg/Munich, Germany, May 11, 2023 M...
May 10, 2023
- On-Target Effect of Trilaciclib Reduces Rates of Multiple Adverse Events Associated with Sacituzumab Govitecan-Hziy by Over 50% Including Neutropenia, Anemia, and Diarrhea - - Most Enrolled... | May 10, 2023
May 10, 2023
- On-Target Effect of Trilaciclib Reduces Rates of Multiple Adverse Events Associated with Sacituzumab Govitecan-Hziy by Over 50% Including Neutropenia,...